publication . Article . 2012

P05.50. CONSORT extension for N-of-1 trials (CENT) guidelines

Sunita Vohra; Douglas G. Altman; David Moher; Nick Barrowman; Larissa Shamseer; Margaret Sampson; Cecilia Bukutu;
Open Access
  • Published: 01 Jun 2012 Journal: BMC Complementary and Alternative Medicine, volume 12, page P410 (issn: 1472-6882, Copyright policy)
  • Publisher: Springer Nature
Abstract
Purpose N-of-1 trials have been used in medicine to generate treatment information when evidence from randomized controlled trials (RCTs) is not available or applicable. Nof-1 study design maintains the methodological safeguards provided by RCTs (blinding, randomization and controls) yet avoids the disadvantages associated with large trials. A standardized method of reporting of N-of1 trials, such as the Consolidated Standards of Reporting Trials (CONSORT), would greatly improve the quality and consistency of trial reports in this area. The objective of this study was to develop a CONSORT Extension for N-of-1 Trials (CENT).
Subjects
Medical Subject Headings: humanities
free text keywords: Complementary and alternative medicine, General Medicine, Poster Presentation, Other systems of medicine, RZ201-999, Randomized controlled trial, law.invention, law, N of 1 trial, Blinding, Consolidated Standards of Reporting Trials, Intensive care medicine, medicine.medical_specialty, medicine, Critical appraisal, Clinical care, Alternative medicine, Randomization, business.industry, business
Funded by
NIH| International Research Conference on Integrative Medicine
Project
  • Funder: National Institutes of Health (NIH)
  • Project Code: 3R13AT007128-01S1
  • Funding stream: NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE
Any information missing or wrong?Report an Issue